Etonogestrel-releasing intrauterine system - Merck & Co.

Drug Profile

Etonogestrel-releasing intrauterine system - Merck & Co.

Alternative Names: ENG-MIUS; MK-8342; ORG 299001; SCH 900342

Latest Information Update: 07 Oct 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Merck & Co
  • Class Hormonal contraceptives; Norpregnanes; Phenanthrenes; Progesterone congeners; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pregnancy

Most Recent Events

  • 11 Aug 2015 Discontinued - Phase-II for Pregnancy (Prevention) in Germany and the Netherlands (Intrauterine)
  • 31 Oct 2014 Phase-II development is ongoing for Contraception/Pregnancy (Prevention)
  • 27 Jul 2012 Phase-II development is ongoing for Contraception/Pregnancy (Prevention)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top